Law Firm Coalition Secures $7.25 Billion Monsanto Roundup Settlement for Cancer Claims

Williams Hart & Boundas, LLP has joined a team of leading plaintiffs' law firms to achieve a $7.25 billion settlement class action against Monsanto that would resolve thousands of existing and future claims involving Roundup exposure and non-Hodgkin lymphoma (NHL). The settlement, filed on February 17, 2026, by Williams Hart & Boundas, Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm, in the City of St. Louis Circuit Court will establish a structured compensation framework for individuals diagnosed with NHL following exposure to Monsanto's glyphosate-based herbicide. Over the past several years, juries nationwide have returned significant verdicts linking Roundup to non-Hodgkin lymphoma, while tens of thousands of claims remain pending in state and federal courts.

According to the settlement, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims. The agreement is designed to provide a structured and comprehensive resolution framework for individuals diagnosed with non-Hodgkin lymphoma following exposure to the herbicide. John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas, LLP stated that after years of pressing cases against Monsanto and in light of the fact that the U.S. Supreme Court has accepted an appeal to review the validity of these Round-Up claims, the firm is pleased to achieve a resolution that is acceptable based on the current circumstances.

Under the proposed settlement, eligible class members will have the right to opt out and pursue their claims individually if they choose. The case is filed in St. Louis city court. This settlement represents one of the largest mass tort resolutions in recent history and addresses ongoing litigation that has spanned multiple jurisdictions. The structured compensation framework aims to provide timely resolution for claimants while acknowledging the scientific and legal complexities surrounding glyphosate exposure claims. The involvement of multiple prominent plaintiffs' firms underscores the significance of this litigation and the coordinated effort required to achieve such a comprehensive settlement.

The resolution comes at a critical juncture as the U.S. Supreme Court prepares to review the validity of Roundup claims, potentially affecting thousands of pending cases. By establishing this settlement framework before the Supreme Court's decision, the parties have created a pathway for compensation regardless of the eventual legal outcome. This approach provides certainty for both claimants and the defendant while addressing public health concerns raised by extensive litigation. The settlement's magnitude reflects the scale of alleged harm and the persistent legal challenges faced by Monsanto regarding its flagship herbicide product. More information about the legal proceedings can be found at https://www.24-7pressrelease.com.